Relation Rx

Relation Therapeutics (Relation Rx) is a London- and Boston-based end-to-end biotechnology company developing transformational medicines with technology at its core. The company combines single-cell multi-omics analysis of patient tissue, functional genomics and disease-relevant assays, and machine learning to decode disease biology, identify and validate therapeutic targets, and advance its own pipeline of drug candidates. Relation is a DCVC portfolio company and has announced research collaborations with partners including Novartis. It operates as a therapeutics developer rather than a software or API provider, and publishes no public developer API, developer portal, SDKs, or machine-readable API specifications at this time.

Relation Rx is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Pharmaceuticals, Drug Discovery, and Machine-Learning.

Relation Rx’s developer surface includes engineering blog and 3 more developer resources.

6.7/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-08-20 · rubric v0.12.0
0 APIs
CompanyBiotechnologyPharmaceuticalsDrug DiscoveryMachine-LearningGenomicsMultiomicsTherapeuticsLife Sciences

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-08-20 · rubric v0.12.0
Composite quality — 6.7/100 · minimal
Contract Quality 0.0 / 21
Developer Ergonomics 0.4 / 17
Access Clarity 1.8 / 17
Operational Transparency 0.0 / 11
Contract Governance 0.0 / 10
Discoverability 4.3 / 9
Regulatory Posture 1.9 / 15
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 10
Documented Reversibility 0 / 6
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
A2A Agent Card 0 / 8
Dry-Run / Simulate Mode 0 / 4
Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.
The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/relation-rx: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Relation Rx Domain Security

TLSv1.3 · HSTS · DNSSEC · DMARC

SECURITY

Resources

Access & Security 1

Authentication, authorization, and security posture

Commercial 1

Pricing, plans, and the legal terms of use

Company 2

The organization behind the API

Source (apis.yml)

apis.yml Raw ↑
aid: relation-rx
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/relation-rx.png
name: Relation Rx
description: Relation Therapeutics (Relation Rx) is a London- and Boston-based end-to-end biotechnology company developing
  transformational medicines with technology at its core. The company combines single-cell multi-omics analysis of patient
  tissue, functional genomics and disease-relevant assays, and machine learning to decode disease biology, identify and validate
  therapeutic targets, and advance its own pipeline of drug candidates. Relation is a DCVC portfolio company and has announced
  research collaborations with partners including Novartis. It operates as a therapeutics developer rather than a software
  or API provider, and publishes no public developer API, developer portal, SDKs, or machine-readable API specifications at
  this time.
url: https://raw.githubusercontent.com/api-evangelist/relation-rx/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- dcvc
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.23'
created: '2026-07-17'
modified: '2026-07-21'
tags:
- Company
- Biotechnology
- Pharmaceuticals
- Drug Discovery
- Machine-Learning
- Genomics
- Multiomics
- Therapeutics
- Life Sciences
tags_raw:
- Company
- Biotechnology
- Pharmaceuticals
- Drug Discovery
- Machine Learning
- Genomics
- Multi-omics
- Therapeutics
- Life Sciences
apis: []
common:
- type: DomainSecurity
  url: security/relation-rx-domain-security.yml
- type: Website
  url: https://www.relationrx.com
- type: PrivacyPolicy
  url: https://www.relationrx.com/privacy-policy
- type: Blog
  url: https://www.relationrx.com/news
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
x-enrichment:
  date: '2026-07-21'
  status: minimal
  artifacts_added: 1
  pass: local-v1